54 results
POS AM
v9d9udgnt nwh3d9w
3 Mar 22
Prospectus update (post-effective amendment)
8:29am
8-K
EX-99.1
aacvg8nqzmiulf3bh
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
POSASR
takzgrmyuik
3 Mar 22
Automatic shelf registration (post-effective amendment)
7:00am
8-K
ksfwz
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
EX-99.1
g5nt4z2m0ka0 xw
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am